← Back to screener

LB PHARMACEUTICALS INC LBRX

Rank #1488 · Nasdaq · $1.1B market cap
Audited by BDO USA, P.C, no going-concern flag in the latest filing.
Score
47.6
P/E
-18.0
P/B
-33.02
ROE
183.0%
Op. Margin
–%
Debt Ratio
-40%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -18.0x, P/B -33.02x. Ranks in the top 89% of the universe.

Profitability ★★★★★
Excellent

ROE 183.0%. Ranks in the top 2% of the universe.

Safety ★★★★★
Excellent

Debt ratio -40%. Ranks in the top 6% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2025––$-0.1B$-0.0B–-40

← See the full screener